已收盘 08-01 16:00:00 美东时间
-0.960
-3.25%
Exelixis Q2 revenue missed estimates, but strong Cabometyx sales lifted earnings. STELLAR trial delays and strategy shifts shaped the update.
07-30 00:32
Stellar Bancorp (NYSE:STEL) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.45 by 14.35 percent. This is a 8.93 percent decrease over earnings of $0.56 per share from the
07-25 19:01
Companies Reporting Before The Bell • Eni (NYSE:E) is likely to report quarterl...
07-25 16:32
IQSTEL Inc. (NASDAQ:IQST), a leading provider of telecom, fintech, AI, and cybersecurity services, today released a comprehensive shareholder letter recapping a recent investor interview conducted by Michael Poarch
07-25 03:00
Stellar Bancorp (NYSE:STEL) is set to give its latest quarterly earnings report...
07-24 23:02
IQSTEL (NASDAQ:IQST) on Thursday announced 1H 2025 preliminary unaudited revenue of $128.8 million. June alone contributed $27.3 million, a significant increase from May's $23.7 million. Starting July...
07-17 21:11
Shenandoah Telecommunications Company will release its Q2 2025 financial results on July 31, 2025, after market close, and host a conference call at 4:30 PM ET to discuss the results. The call will be available via webcast and a replay will be accessible on the company’s Investor Relations page. Shentel provides broadband services through fiber optic and cable networks across eight eastern U.S. states, offering internet, video, voice, and managed...
07-17 20:05
KBR (NYSE:KBR) announced that its joint venture with SOCAR, SOCAR-KBR LLC, has secured two contracts from BP in Azerbaijan. These projects include providing support for the Sangachal Terminal Electrif...
07-15 18:24
IQSTEL Inc. (NASDAQ:IQST), a leading global telecommunications and technology company, is pleased to announce a significant reduction of $6.9 million in debt from its balance sheet, marking a strategic milestone in the
07-09 20:37
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 8, 2025 /PRNewswire/ -- Equity Insider News Commentary – As cancer rates climb and drug costs c...
07-08 22:25